Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Cephalosporin Market Report 2017

  • QYR2416802
  • 119 Pages
  • January 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the United States Cephalosporin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Cephalosporin in these regions, from 2012 to 2022 (forecast).

United States Cephalosporin market competition by top manufacturers/players, with Cephalosporin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Union Chempharma

NCPC

Qilu Antibiotics

Lupin Pharmaceuticals

Hospira

Dhanuka Laboratories

Fukang

Dongying Pharmaceutical

Alkem

SALUBRIS

LIVZON

Hetero Drugs

CSPC

TEVA

Orchid Pharma

Taj Pharmaceuticals

Covalent Laboratories

United Laboratories

Aurobindo

Wockhardt

LKPC

HPGC

Huafangpharm

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

First Generation

Second Generation

Third Generation

Fourth Generation

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Oral

Injection

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Cephalosporin Market Report 2017

1 Cephalosporin Overview

1.1 Product Overview and Scope of Cephalosporin

1.2 Classification of Cephalosporin by Product Category

1.2.1 United States Cephalosporin Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Cephalosporin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 First Generation

1.2.4 Second Generation

1.2.5 Third Generation

1.2.6 Fourth Generation

1.3 United States Cephalosporin Market by Application/End Users

1.3.1 United States Cephalosporin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Oral

1.3.3 Injection

1.4 United States Cephalosporin Market by Region

1.4.1 United States Cephalosporin Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Cephalosporin Status and Prospect (2012-2022)

1.4.3 Southwest Cephalosporin Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Cephalosporin Status and Prospect (2012-2022)

1.4.5 New England Cephalosporin Status and Prospect (2012-2022)

1.4.6 The South Cephalosporin Status and Prospect (2012-2022)

1.4.7 The Midwest Cephalosporin Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Cephalosporin (2012-2022)

1.5.1 United States Cephalosporin Sales and Growth Rate (2012-2022)

1.5.2 United States Cephalosporin Revenue and Growth Rate (2012-2022)

2 United States Cephalosporin Market Competition by Players/Suppliers

2.1 United States Cephalosporin Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Cephalosporin Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Cephalosporin Average Price by Players/Suppliers (2012-2017)

2.4 United States Cephalosporin Market Competitive Situation and Trends

2.4.1 United States Cephalosporin Market Concentration Rate

2.4.2 United States Cephalosporin Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Cephalosporin Manufacturing Base Distribution, Sales Area, Product Type

3 United States Cephalosporin Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Cephalosporin Sales and Market Share by Region (2012-2017)

3.2 United States Cephalosporin Revenue and Market Share by Region (2012-2017)

3.3 United States Cephalosporin Price by Region (2012-2017)

4 United States Cephalosporin Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Cephalosporin Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Cephalosporin Revenue and Market Share by Type (2012-2017)

4.3 United States Cephalosporin Price by Type (2012-2017)

4.4 United States Cephalosporin Sales Growth Rate by Type (2012-2017)

5 United States Cephalosporin Sales (Volume) by Application (2012-2017)

5.1 United States Cephalosporin Sales and Market Share by Application (2012-2017)

5.2 United States Cephalosporin Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Cephalosporin Players/Suppliers Profiles and Sales Data

6.1 Union Chempharma

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Cephalosporin Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Union Chempharma Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 NCPC

6.2.2 Cephalosporin Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 NCPC Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Qilu Antibiotics

6.3.2 Cephalosporin Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Qilu Antibiotics Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Lupin Pharmaceuticals

6.4.2 Cephalosporin Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Lupin Pharmaceuticals Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Hospira

6.5.2 Cephalosporin Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Hospira Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Dhanuka Laboratories

6.6.2 Cephalosporin Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Dhanuka Laboratories Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Fukang

6.7.2 Cephalosporin Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Fukang Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Dongying Pharmaceutical

6.8.2 Cephalosporin Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Dongying Pharmaceutical Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Alkem

6.9.2 Cephalosporin Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Alkem Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 SALUBRIS

6.10.2 Cephalosporin Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 SALUBRIS Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 LIVZON

6.12 Hetero Drugs

6.13 CSPC

6.14 TEVA

6.15 Orchid Pharma

6.16 Taj Pharmaceuticals

6.17 Covalent Laboratories

6.18 United Laboratories

6.19 Aurobindo

6.20 Wockhardt

6.21 LKPC

6.22 HPGC

6.23 Huafangpharm

7 Cephalosporin Manufacturing Cost Analysis

7.1 Cephalosporin Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Cephalosporin

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Cephalosporin Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Cephalosporin Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Cephalosporin Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Cephalosporin Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Cephalosporin Sales Volume Forecast by Type (2017-2022)

11.3 United States Cephalosporin Sales Volume Forecast by Application (2017-2022)

11.4 United States Cephalosporin Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Cephalosporin

Figure United States Cephalosporin Market Size (K MT) by Type (2012-2022)

Figure United States Cephalosporin Sales Volume Market Share by Type (Product Category) in 2016

Figure First Generation Product Picture

Figure Second Generation Product Picture

Figure Third Generation Product Picture

Figure Fourth Generation Product Picture

Figure United States Cephalosporin Market Size (K MT) by Application (2012-2022)

Figure United States Sales Market Share of Cephalosporin by Application in 2016

Figure Oral Examples

Table Key Downstream Customer in Oral

Figure Injection Examples

Table Key Downstream Customer in Injection

Figure United States Cephalosporin Market Size (Million USD) by Region (2012-2022)

Figure The West Cephalosporin Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Cephalosporin Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Cephalosporin Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Cephalosporin Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Cephalosporin Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Cephalosporin Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Cephalosporin Sales (K MT) and Growth Rate (2012-2022)

Figure United States Cephalosporin Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Cephalosporin Market Major Players Product Sales Volume (K MT) (2012-2017)

Table United States Cephalosporin Sales (K MT) of Key Players/Suppliers (2012-2017)

Table United States Cephalosporin Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Cephalosporin Sales Share by Players/Suppliers

Figure 2017 United States Cephalosporin Sales Share by Players/Suppliers

Figure United States Cephalosporin Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Cephalosporin Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Cephalosporin Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Cephalosporin Revenue Share by Players/Suppliers

Figure 2017 United States Cephalosporin Revenue Share by Players/Suppliers

Table United States Market Cephalosporin Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)

Figure United States Market Cephalosporin Average Price (USD/Kg) of Key Players/Suppliers in 2016

Figure United States Cephalosporin Market Share of Top 3 Players/Suppliers

Figure United States Cephalosporin Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Cephalosporin Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Cephalosporin Product Category

Table United States Cephalosporin Sales (K MT) by Region (2012-2017)

Table United States Cephalosporin Sales Share by Region (2012-2017)

Figure United States Cephalosporin Sales Share by Region (2012-2017)

Figure United States Cephalosporin Sales Market Share by Region in 2016

Table United States Cephalosporin Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Cephalosporin Revenue Share by Region (2012-2017)

Figure United States Cephalosporin Revenue Market Share by Region (2012-2017)

Figure United States Cephalosporin Revenue Market Share by Region in 2016

Table United States Cephalosporin Price (USD/Kg) by Region (2012-2017)

Table United States Cephalosporin Sales (K MT) by Type (2012-2017)

Table United States Cephalosporin Sales Share by Type (2012-2017)

Figure United States Cephalosporin Sales Share by Type (2012-2017)

Figure United States Cephalosporin Sales Market Share by Type in 2016

Table United States Cephalosporin Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Cephalosporin Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Cephalosporin by Type (2012-2017)

Figure Revenue Market Share of Cephalosporin by Type in 2016

Table United States Cephalosporin Price (USD/Kg) by Types (2012-2017)

Figure United States Cephalosporin Sales Growth Rate by Type (2012-2017)

Table United States Cephalosporin Sales (K MT) by Application (2012-2017)

Table United States Cephalosporin Sales Market Share by Application (2012-2017)

Figure United States Cephalosporin Sales Market Share by Application (2012-2017)

Figure United States Cephalosporin Sales Market Share by Application in 2016

Table United States Cephalosporin Sales Growth Rate by Application (2012-2017)

Figure United States Cephalosporin Sales Growth Rate by Application (2012-2017)

Table Union Chempharma Basic Information List

Table Union Chempharma Cephalosporin Sales (K MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Union Chempharma Cephalosporin Sales Growth Rate (2012-2017)

Figure Union Chempharma Cephalosporin Sales Market Share in United States (2012-2017)

Figure Union Chempharma Cephalosporin Revenue Market Share in United States (2012-2017)

Table NCPC Basic Information List

Table NCPC Cephalosporin Sales (K MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure NCPC Cephalosporin Sales Growth Rate (2012-2017)

Figure NCPC Cephalosporin Sales Market Share in United States (2012-2017)

Figure NCPC Cephalosporin Revenue Market Share in United States (2012-2017)

Table Qilu Antibiotics Basic Information List

Table Qilu Antibiotics Cephalosporin Sales (K MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Qilu Antibiotics Cephalosporin Sales Growth Rate (2012-2017)

Figure Qilu Antibiotics Cephalosporin Sales Market Share in United States (2012-2017)

Figure Qilu Antibiotics Cephalosporin Revenue Market Share in United States (2012-2017)

Table Lupin Pharmaceuticals Basic Information List

Table Lupin Pharmaceuticals Cephalosporin Sales (K MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Lupin Pharmaceuticals Cephalosporin Sales Growth Rate (2012-2017)

Figure Lupin Pharmaceuticals Cephalosporin Sales Market Share in United States (2012-2017)

Figure Lupin Pharmaceuticals Cephalosporin Revenue Market Share in United States (2012-2017)

Table Hospira Basic Information List

Table Hospira Cephalosporin Sales (K MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Hospira Cephalosporin Sales Growth Rate (2012-2017)

Figure Hospira Cephalosporin Sales Market Share in United States (2012-2017)

Figure Hospira Cephalosporin Revenue Market Share in United States (2012-2017)

Table Dhanuka Laboratories Basic Information List

Table Dhanuka Laboratories Cephalosporin Sales (K MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Dhanuka Laboratories Cephalosporin Sales Growth Rate (2012-2017)

Figure Dhanuka Laboratories Cephalosporin Sales Market Share in United States (2012-2017)

Figure Dhanuka Laboratories Cephalosporin Revenue Market Share in United States (2012-2017)

Table Fukang Basic Information List

Table Fukang Cephalosporin Sales (K MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Fukang Cephalosporin Sales Growth Rate (2012-2017)

Figure Fukang Cephalosporin Sales Market Share in United States (2012-2017)

Figure Fukang Cephalosporin Revenue Market Share in United States (2012-2017)

Table Dongying Pharmaceutical Basic Information List

Table Dongying Pharmaceutical Cephalosporin Sales (K MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Dongying Pharmaceutical Cephalosporin Sales Growth Rate (2012-2017)

Figure Dongying Pharmaceutical Cephalosporin Sales Market Share in United States (2012-2017)

Figure Dongying Pharmaceutical Cephalosporin Revenue Market Share in United States (2012-2017)

Table Alkem Basic Information List

Table Alkem Cephalosporin Sales (K MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Alkem Cephalosporin Sales Growth Rate (2012-2017)

Figure Alkem Cephalosporin Sales Market Share in United States (2012-2017)

Figure Alkem Cephalosporin Revenue Market Share in United States (2012-2017)

Table SALUBRIS Basic Information List

Table SALUBRIS Cephalosporin Sales (K MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure SALUBRIS Cephalosporin Sales Growth Rate (2012-2017)

Figure SALUBRIS Cephalosporin Sales Market Share in United States (2012-2017)

Figure SALUBRIS Cephalosporin Revenue Market Share in United States (2012-2017)

Table LIVZON Basic Information List

Table Hetero Drugs Basic Information List

Table CSPC Basic Information List

Table TEVA Basic Information List

Table Orchid Pharma Basic Information List

Table Taj Pharmaceuticals Basic Information List

Table Covalent Laboratories Basic Information List

Table United Laboratories Basic Information List

Table Aurobindo Basic Information List

Table Wockhardt Basic Information List

Table LKPC Basic Information List

Table HPGC Basic Information List

Table Huafangpharm Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Cephalosporin

Figure Manufacturing Process Analysis of Cephalosporin

Figure Cephalosporin Industrial Chain Analysis

Table Raw Materials Sources of Cephalosporin Major Players/Suppliers in 2016

Table Major Buyers of Cephalosporin

Table Distributors/Traders List

Figure United States Cephalosporin Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure United States Cephalosporin Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Cephalosporin Price (USD/Kg) Trend Forecast (2017-2022)

Table United States Cephalosporin Sales Volume (K MT) Forecast by Type (2017-2022)

Figure United States Cephalosporin Sales Volume (K MT) Forecast by Type (2017-2022)

Figure United States Cephalosporin Sales Volume (K MT) Forecast by Type in 2022

Table United States Cephalosporin Sales Volume (K MT) Forecast by Application (2017-2022)

Figure United States Cephalosporin Sales Volume (K MT) Forecast by Application (2017-2022)

Figure United States Cephalosporin Sales Volume (K MT) Forecast by Application in 2022

Table United States Cephalosporin Sales Volume (K MT) Forecast by Region (2017-2022)

Table United States Cephalosporin Sales Volume Share Forecast by Region (2017-2022)

Figure United States Cephalosporin Sales Volume Share Forecast by Region (2017-2022)

Figure United States Cephalosporin Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370